Palmitoleic acid isomer (C16:1Δ6) in human skin sebum is effective against gram-positive bacteria

Skin Pharmacology and Applied Skin Physiology

Volumn 16, Issue 3, 2003, Pages 176-187

  Wille, John J ^a,c   Kydonieus, A ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b Samos Pharmaceuticals   (United States)

^c Bioderm Technologies Inc   (United States)

Author keywords

Antimicrobial agents; Natural preservatives; Palmitoleic acid; Sebum; Skin lipids

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CERAMIDE DERIVATIVE; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID; PALMITOLEIC ACID; PSEUDOMONIC ACID; SATURATED FATTY ACID; SQUALENE; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PURIFICATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LIPID ANALYSIS; LIPID COMPOSITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEBUM; STRATUM CORNEUM; THIN LAYER CHROMATOGRAPHY;

ANIMALS; ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CHEMICAL FRACTIONATION; EPIDERMIS; FATTY ACIDS, MONOUNSATURATED; GRAM-POSITIVE BACTERIA; HUMANS; ISOMERISM; MICROBIAL SENSITIVITY TESTS; SEBUM; SWINE; TIME FACTORS;

EID: 0037247566     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069757     Document Type: Article

References (46)

1. Burtenshaw JML: The mechanism of self-sterilization of human skin and its appendages. J Hyg 1942;42: 84-209.
2. Chai T-J, Chai TC: Bactericidal activity of cerumen. Antimicrob Agents Chemother 1980;18:638-641.
3. Stone M, Fulgum RS: Bactericidal activity of wet cerumen. Ann Otol Rhinol Laryngol 1984;93:183-186.
4. Leyden JJ, McGinley KJ, Nordstrom KM, Webster GF: Skin microflora. J Invest Dermatol 1987;88(suppl):65s-72s.
5. Law S, Fotos PG, Wertz PW: Skin surface lipids inhibit adherence of Candida albicans to stratum corneum. Dermatology 1997;195:220-223.
6. Ghannoum MA, Burns GR, Elteen KA, Radwan SS: Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells. Infect Immun 1986;54:189-193.
7. Ghannoum MA, Elteen KA, Radwan SS: Blocking adherence of Candida albicans to buccal epithelial cells by yeast glycolipids, yeast wall lipids and lipids from epithelial cells. Mykosen 1987;30:371-378.
8. Kennedy MJ, Rogers AL, Hanselmen LR, Soll DR, Yancey RJ: Variation in adhesion and cell surface hydrophobicity inCandida albicans white and opaque phenotypes. Mycopathologia 1988;102:149-156.
9. Mishra P, Bolard J, Prasad R: Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast. Biochim Biophys Acta 1992;1127:1-14.
10. Gunstone W: The Lipid Handbook. London, Chapman & Hall, 1989.
11. Wille JJ, et al: Antimicrobial Lipids. Patent No. WO 09816104, issued April 1998.
12. Spiral plating methodology by Dr. Drake; pers. commun.
13. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM: Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001;117:44-51.
14. Thielitz A, Helmdach M, Ropke EM, and Gollnick H: Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents. Br J Dermatol 2001;145:19-27.
15. Zouboulis CC, Xia L, Detmar M, Bogdanoff B, Giannakopoulis G, Gollnick H, Orfanis CE: Culture of human sebocytes and markers of subacid differentiation in vitro. Skin Pharmacol 1991;4:74-83.
16. Zouboulis CC, Xia L, Akamatsu H, et al: The human subacid culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998;196:21-31.
17. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE: Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999;113:1011-1020.
18. Thiele JJ, Weber SU, Packer L: Sebaceous gland secretion is a major physiological route of vitamin E delivery to the skin. J Invest Dermatol 1999;113:1006-1010.
19. Zouboulis CC, et al: The skin as a factory of androgens (abstract). Horm Res 2000;53:92.
20. Chattaway FW, Thompson CC, Barlow AJE: Action of inhibitors on dermatophytes. Biochem J 1956;63:648-656.
21. Glassman HN: Surface active agents and their application in bacteriology. Bacteriol Rev 1948;12:105-148.
22. Prince HN: Effect of pH on the anti-fungal activity of undecylenic acid and its calcium salt. J Bacteriol 1959;78:788-791.
23. Marples RR, Downing DT, Kligman AM: Control of free fatty acids in human surface lipids by Corynebacterium acnes. J Invest Dermatol 1971;56:127-131.
24. Kearney JN, Ingham E., Cunliffe WJ, Holland KT: Correlations between human skin bacteria and skin lipids. Br J Dermatol 1984;10:593-599.
25. Effendy I, Maibach HI: Surfactants and experimental irritant contact dermatitis. Contact Dermatitis 1995;33:217-225.
26. Bayliss M: Effect of the chemical constituents of soaps upon their germicidal properties. J Bacteriol 1936;31:489-504.
27. Nicolaides N: Skin lipids: Their biochemical uniqueness. Science 1974;186:19-24.
28. Kabara JJ, Swieczkowski DM, Conley AJ, Truant J: Fatty acids and derivatives as antimicrobial agents. Antimicrobiol Agents Chemother 1972;2:23-28.
29. Miller SJ, Ally R, Shinefield HR, Elias PM: In vitro and in vivo corneum lipids. Arch Dermatol 1988;124:209-215.
30. Bibel DJ, Miller SJ, Brown BE, Pandey BB, Elias PM, Shinefield HR, Aly R: Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol 1989;92:632-638.
31. Bibel DJ, Aly, R, Shinefield HR: Antimicrobial activity of sphingosines. J Invest Dermatol 1992;98:269-273.
32. Wertz PW, Downing DT: Free sphingosine in human epidermis. J Invest Dermatol 1990;94:159-161.
33. Downing DT, Dose RW, Abraham W: Interaction between sphingosine and cholesteryl sulfate in epidermal lipids. J Lipid Res 1993;34:563-569.
34. Conley AJ, Kabara JJ: Antimicrobial action of esters of polyhydric alcohols. Antimicrob Agents Chemother 1973;4:501-506.
35. Hazell SL, Graham DY: Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol 1990;28:1060-1061.
36. Kabara JJ: Fatty acids and derivatives as antimicrobial agents: A review; in Kabara JJ (ed): The Pharmacological Effects of Lipids. Champaign, American Oil Chemist Society, 1978, pp 1-14.
37. Kato N, Shibasaki I: Comparison of antimicrobial activities of fatty acids and their esters. J Ferment Technol 1975;53:793-801.
38. Knapp HR, Mealy MA: Bactericidal effects of polyunsaturated fatty acids. J Infect Dis 1986;154:84-94.
39. Coaticook E: The effect of unsaturated fatty acids on gram-positive bacteria. Soc Exp Biol SGMP 1949;3:217-232.
40. Nieman C: Influence of trace amounts of fatty acids on the growth of microorganisms. Bacterial Rev 1954;18:147-163.
41. Sivasaki I, Kato N: Combined effects on antibacterial activity of fatty acids and their esters against gram-positive bacteria; in Kabara JJ (ed): The Pharmacological Effects of Lipids. Champaign, American Oil Chemist Society, 1978, pp 23-35.
42. Thompson L, Cockayne A, Sapiller RC: Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: A possible explanation of the effect of diet on peptic ulceration. Gut 1994;35:1557-1561.
43. Petschow BW, Batema RP, Ford LL: Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agent Chemother 1996;40:302-306.
44. Katz DH, Marcelletti JF, Khalil MH, Pope E, Katz LR: Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex. Proc Natl Acad Sci USA 1991;88:10825-10829.
45. Windholz M, et al: Undecylenic acid; in Windholz M, et al (eds): The Merck Index, ed 10. Rahway, Merck, 1983, p. 1408.
46. Miner N, Armstrong M: Comparative ability of various prescription and over-the-counter topical anti-fungal drug products to inhibit the growth of C. albicans. Adv Wound Care 1994;7:53-55.